Ing Groep Nv Idexx Laboratories Inc Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Ing Groep Nv holds 16,754 shares of IDXX stock, worth $7.07 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,754

Previous 18,602 9.93%

Holding current value

$7.07 Million

Previous $9.06 Million 6.63%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$455.08 - $517.19 $840,987 - $955,767	-1,848 Reduced 9.93%	16,754 $8.46 Million
Q2 2024 Aug 13, 2024	SELL	$468.04 - $548.53 $644,959 - $755,874	-1,378 Reduced 6.9%	18,602 $9.06 Million
Q1 2024 May 10, 2024	BUY	$515.08 - $576.87 $682,996 - $764,929	1,326 Added 7.11%	19,980 $10.8 Million
Q4 2023 Feb 08, 2024	BUY	$391.37 - $557.56 $7.06 Million - $10.1 Million	18,048 Added 2978.22%	18,654 $10.4 Million
Q3 2023 Oct 27, 2023	SELL	$432.42 - $556.67 $847,110 - $1.09 Million	-1,959 Reduced 76.37%	606 $264,000
Q2 2023 Aug 07, 2023	SELL	$450.7 - $503.61 $7.57 Million - $8.46 Million	-16,801 Reduced 86.76%	2,565 $1.29 Million
Q1 2023 May 09, 2023	BUY	$406.01 - $514.59 $1.42 Million - $1.8 Million	3,502 Added 22.08%	19,366 $9.68 Million
Q4 2022 Feb 10, 2023	BUY	$324.64 - $441.27 $4.51 Million - $6.12 Million	13,879 Added 699.19%	15,864 $6.47 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $2.52 Million - $3.15 Million	-7,724 Reduced 79.56%	1,985 $647,000
Q2 2022 Aug 08, 2022	SELL	$327.37 - $553.44 $2.83 Million - $4.78 Million	-8,639 Reduced 47.08%	9,709 $3.41 Million
Q1 2022 May 13, 2022	BUY	$466.52 - $631.01 $1.72 Million - $2.32 Million	3,679 Added 25.08%	18,348 $10 Million
Q4 2021 Feb 11, 2022	BUY	$586.54 - $666.48 $3.54 Million - $4.02 Million	6,029 Added 69.78%	14,669 $9.66 Million
Q3 2021 Nov 02, 2021	BUY	$621.9 - $705.76 $82,090 - $93,160	132 Added 1.55%	8,640 $5.37 Million
Q2 2021 Aug 13, 2021	BUY	$486.36 - $637.08 $1.39 Million - $1.82 Million	2,852 Added 50.42%	8,508 $5.37 Million
Q1 2021 May 12, 2021	SELL	$465.18 - $551.79 $930 - $1,103	-2 Reduced 0.04%	5,656 $2.77 Million
Q4 2020 Feb 11, 2021	BUY	$383.85 - $499.87 $1.45 Million - $1.89 Million	3,776 Added 200.64%	5,658 $2.83 Million
Q3 2020 Nov 12, 2020	BUY	$334.54 - $406.31 $389,404 - $472,944	1,164 Added 162.12%	1,882 $740,000
Q2 2020 Aug 13, 2020	SELL	$230.66 - $330.16 $195,138 - $279,315	-846 Reduced 54.09%	718 $237,000
Q1 2020 May 06, 2020	SELL	$182.94 - $290.97 $790,300 - $1.26 Million	-4,320 Reduced 73.42%	1,564 $379,000
Q4 2019 Feb 10, 2020	SELL	$248.66 - $285.01 $2.49 Million - $2.85 Million	-10,000 Reduced 62.96%	5,884 $1.54 Million
Q3 2019 Nov 08, 2019	SELL	$260.07 - $289.93 $2.53 Million - $2.82 Million	-9,737 Reduced 38.0%	15,884 $4.32 Million
Q2 2019 Aug 12, 2019	BUY	$215.53 - $275.33 $21,337 - $27,257	99 Added 0.39%	25,621 $7.05 Million
Q1 2019 May 13, 2019	BUY	$178.02 - $225.69 $1.77 Million - $2.24 Million	9,932 Added 63.71%	25,522 $5.71 Million
Q4 2018 Feb 13, 2019	BUY	$176.18 - $248.92 $2.25 Million - $3.18 Million	12,784 Added 455.6%	15,590 $2.9 Million
Q3 2018 Nov 06, 2018	SELL	$218.82 - $254.46 $4.04 Million - $4.7 Million	-18,481 Reduced 86.82%	2,806 $701,000
Q2 2018 Aug 10, 2018	BUY	$185.56 - $227.9 $82,017 - $100,731	442 Added 2.12%	21,287 $4.64 Million
Q1 2018 May 07, 2018	BUY	$157.81 - $204.73 $4,103 - $5,322	26 Added 0.12%	20,845 $3.99 Million
Q4 2017 Feb 06, 2018	BUY	$147.68 - $168.37 $2.63 Million - $3 Million	17,840 Added 598.86%	20,819 $3.26 Million
Q3 2017 Nov 08, 2017	BUY	$150.32 - $166.46 $447,803 - $495,884	2,979	2,979 $463,000

Others Institutions Holding IDXX

# of Institutions

1,211

Shares Held

73.3M

Call Options Held

167K

Put Options Held

343K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $35.1B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account